$schema: "http://json-schema.org/draft-04/schema#"

id: "core_metadata_collection"
title: Core Metadata Collection
type: object
namespace: https://niaid-clinical-trials-dictionary.org
category: administrative
program: '*'
project: '*'
description: >
  Structured description of a collection of several datasets
additionalProperties: false
submittable: true
validators: null

systemProperties:
  - id
  - project_id
  - state
  - created_datetime
  - updated_datetime

links:
  - name: projects
    backref: core_metadata_collections
    label: data_from
    target_type: project
    multiplicity: many_to_one
    required: true

uniqueKeys:
  - [id]
  - [project_id, submitter_id]

required:
  - submitter_id
  - type
  - projects
  - most_recent_update_datetime

properties:
  $ref: "_definitions.yaml#/ubiquitous_properties"

  data_category:
    term:
      $ref: "_terms.yaml#/data_category"
    type: string

  data_type:
    term:
      $ref: "_terms.yaml#/data_type"
    type: string

  data_format:
    term:
      $ref: "_terms.yaml#/data_format"
    type: string

  submitted_date:
    description: >
      The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov.
    type: string

  first_posted_date:
    description: >
      The date on which the study record was first available on ClinicalTrials.gov.
    type: string

  last_update_posted_date:
    description: >
      The most recent date on which changes to a study record were made available on ClinicalTrials.gov.
    type: string

  previous_versions:
    description: >
      Dates of dataset updates, other than first available and most recent update.
    type: string

  brief_title:
    description: >
      A short title of the clinical study written in language intended for the lay public. The title should include, where possible, information on the participants, condition being evaluated, and intervention(s) studied.
    type: string

#Prop name from clinicaltrials.gov is official_title
  title:
    description: >
      The title of the clinical study, corresponding to the title of the protocol.
    type: string

  brief_summary:
    description: >
      A short description of the clinical study, including a brief statement of the clinical study's hypothesis, written in language intended for the lay public.
    type: string

# Can be mapped to HL7 FHIR ResearchStudy.description. Prop name from clinicaltrials.gov is detailed_description.
  description:
    description: >
      Extended description of the protocol, including more technical information, if desired. Do not include the entire protocol; do not duplicate information recorded in other data elements, such as Eligibility Criteria or outcome measures.
    type: string

  category:
    description: >
      The nature of the investigation or investigational use for which clinical study information is being submitted.
    enum:
      - "Interventional"
      - "Observational"
      - "Expanded Access"

  study_phase:
    description: >
      For a clinical trial of a drug product (including a biological product), the numerical phase of such clinical trial, consistent with terminology in 21 CFR 312.21 and in 21 CFR 312.85 for phase 4 studies.
    enum:
      - "N/A"
      - "early-phase-1"
      - "phase-1"
      - "phase-1-phase-2"
      - "phase-2"
      - "phase-2-phase-3"
      - "phase-3"
      - "phase-4"

  study_design_allocation:
    description: >
      The method by which participants are assigned to arms in a clinical trial.
    enum:
      - "N/A"
      - "Randomized"
      - "Nonrandomized"

  study_design_intervention_model:
    description: >
       The strategy for assigning interventions to participants.
    enum:
      - "Single Group"
      - "Parallel"
      - "Crossover"
      - "Factorial"
      - "Sequential"

  study_design_masking:
    description: >
      The party or parties involved in the clinical trial who are prevented from having knowledge of the interventions assigned to individual participants.
    enum:
      - "Participant"
      - "Care Provider"
      - "Investigator"
      - "Outcomes Assessor"
      - "No Masking"

  study_design_primary_purpose:
    description: >
      The main objective of the intervention(s) being evaluated by the clinical trial.
    enum:
      - "Treatment"
      - "Prevention"
      - "Diagnostic"
      - "Supportive Care"
      - "Screening"
      - "Health Services"
      - "Basic Science"
      - "Device Feasibility"
      - "Other"

  condition:
    description: >
      The name(s) of the disease(s) or condition(s) studied in the clinical study, or the focus of the clinical study. Use, if available, appropriate descriptors from NLM's Medical Subject Headings (MeSH)-controlled vocabulary thesaurus or terms from another vocabulary, such as the Systematized Nomenclature of Medicine—Clinical Terms (SNOMED CT), that has been mapped to MeSH within the Unified Medical Language System (UMLS) Metathesaurus.
    enum:
      - "COVID-19"
      - "Other"

  intervention_type:
    description: >
      For each intervention studied in the clinical study, the general type of intervention.
    enum:
      - "Drug"
      - "Device"
      - "Biological/Vaccine"
      - "Procedure/Surgery"
      - "Radiation"
      - "Behavioral"
      - "Genetic"
      - "Dietary Supplement"
      - "Combination Product"
      - "Diagnostic Test"
      - "Other"

# HL7 FHIR definition
  focus:
    description: >
      Specify the codes for medications, devices and other interventions.
    enum:
      - "Placebo"
      - "Remdesivir"

#HL7 FHIR definition
  arm_name:
    description: >
      Unique, human-readable label for this arm of the study.
    enum:
      - "Placebo"
      - "Remdesivir"

#HL7 FHIR definition
  arm_type:
    description: >
      Categorization of study arm, e.g. experimental, active comparator, placebo comparater.
    enum:
      - "Experimental"
      - "Active Comparator"
      - "Placebo Comparator"
      - "Sham Comparator"
      - "No Intervention"

#HL7 FHIR definition
  arm:
    description: >
      Describes an expected sequence of events for one of the participants of a study. E.g. Exposure to drug A, wash-out, exposure to drug B, wash-out, follow-up.
    type: string

#HL7 FHIR definition
  arm_description:
    description: >
      A succinct description of the path through the study that would be followed by a subject adhering to this arm.
    type: string

  publications:
    description: >
      Citations to publications related to the protocol: background and/or results. Provide either the PubMed Unique Identifier (PMID) of an article or enter the full bibliographic citation.
    type: string

  recruitment_status:
    description: >
      The recruitment status for the clinical study as a whole, based upon the status of the individual sites. If at least one facility in a multi-site clinical study has an Individual Site Status of "Recruiting," then the Overall Recruitment Status for the study must be "Recruiting."
    enum:
    - "Not yet recruiting"
    - "Recruiting"
    - "Enrolling by invitation"
    - "Active, not recruiting"
    - "Completed"
    - "Suspended"
    - "Terminated"
    - "Withdrawn"

  actual_enrollment:
    description: >
      The number of participants enrolled in the study
    type: string

  original_estimated_enrollment:
    description: >
      Original Estimated Enrollment
    type: string

  study_start_date:
    description: >
      The estimated date on which the clinical study will be open for recruitment of participants, or the actual date on which the first participant was enrolled.
    type: string

  primary_completion_date:
    description: >
      The date that the final participant was examined or received an intervention for the purposes of final collection of data for the primary outcome, whether the clinical study concluded according to the pre-specified protocol or was terminated. In the case of clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all of the primary outcomes.
    type: string

  study_completion_date:
    description: >
      The date the final participant was examined or received an intervention for purposes of final collection of data for the primary and secondary outcome measures and adverse events (for example, last participant’s last visit), whether the clinical study concluded according to the pre-specified protocol or was terminated.
    type: string

  eligibility_criteria:
    description: >
      A limited list of criteria for selection of participants in the clinical study, provided in terms of inclusion and exclusion criteria and suitable for assisting potential participants in identifying clinical studies of interest. Use a bulleted list for each criterion below the headers "Inclusion Criteria" and "Exclusion Criteria".
    type: string

# HL7 FHIR definition
  enrollment:
    description: >
      Reference to a Group that defines the criteria for and quantity of subjects participating in the study. E.g. " 200 female Europeans between the ages of 20 and 45 with early onset diabetes".
    type: string

  accepts_healthy_volunteers:
    description: >
      Indication that participants who do not have a disease or condition, or related conditions or symptoms, under study in the clinical study are permitted to participate in the clinical study.
    enum:
      - "Yes"
      - "No"

#HL7 FHIR definition
  contact:
    description: >
      Contact details to assist a user in learning more about or engaging with the study.
    type: string

# HL7 FHIR definition
  location:
    description: >
      Indicates a country, state or other region where the study is taking place.
    type: array
    items:
      type: string

  locations_removed:
    description: >
      Indicates a country, state or other region that has been removed from the study.
    type: string

  nct_number:
    description: >
      The organization's unique protocol identification number assigned to the clinical study.
    type: string

  secondary_id:
    description: >
      An identifier(s) (ID), if any, other than the organization's Unique Protocol Identification Number or the NCT number that is assigned to the clinical study. This includes any unique clinical study identifiers assigned by other publicly available clinical trial registries. If the clinical study is funded in whole or in part by a U.S. Federal Government agency, the complete grant or contract number must be submitted as a Secondary ID.
    type: string

  has_data_monitoring_committee:
    description: >
      Indicate whether a data monitoring committee has been appointed for this study. The data monitoring committee (board) is a group of independent scientists who are appointed to monitor the safety and scientific integrity of a human research intervention, and to make recommendations to the sponsor regarding the stopping of the trial for efficacy, for harms or for futility. The composition of the committee is dependent upon the scientific skills and knowledge required for monitoring the particular study.
    enum:
      - "Yes"
      - "No"

  fda_regulated_device_product:
    description: >
      Indication that a clinical study is studying a device product subject to section 510(k), 515, or 520(m) of the Federal Food, Drug, and Cosmetic Act.
    enum:
      - "Yes"
      - "No"

  fda_regulated_drug_product:
    description: >
      Indication that a clinical study is studying a drug product (including a biological product) subject to section 505 of the Federal Food, Drug, and Cosmetic Act or to section 351 of the Public Health Service Act.
    enum:
      - "Yes"
      - "No"

  us_product:
    description: >
      Whether any drug product (including a biological product) or device product studied in the clinical study is manufactured in the United States or one of its territories and exported for study in a clinical study in another country. Required if U.S. FDA-regulated Drug and/or U.S. FDA-regulated Device is "Yes," U.S. FDA IND or IDE is "No", and Facility Information does not include at least one U.S. location.
    enum:
      - "Yes"
      - "No"

  ipd_sharing_statement:
    description: >
      Indicate whether there is a plan to make individual participant data (IPD) collected in this study, including data dictionaries, available to other researchers (typically after the end of the study).
    enum:
     - "Yes"
     - "No"
     - "Undecided"

  responsible_party:
    description: >
     An indication of whether the responsible party is the sponsor, the sponsor-investigator, or a principal investigator designated by the sponsor to be the responsible party.
    enum:
    - "Sponsor"
    - "Principle Investigator"
    - "Sponsor-Investigator"

  data_available:
    description: >
     A description of the type of controlled-acccess data that can be requested.
    enum:
    - "Patient-Level Data"
    - "Other"

  data_availability_date:
    description: >
      The date of availability for the controlled access patient-level data. This date indicates when users may request access to this data.
    type: string

  most_recent_update:
    description: >
      The date of the most recent update to the clinical trial dataset.
    type: string

  # Added so we can sort the datasets by most recent update.
  # Needed because the above field is in human-readable format (Month Day) and not sortable.
  most_recent_update_datetime:
    description: >
      Datetime format for the most recent update to the clinical trial dataset.
    $ref: "_definitions.yaml#/datetime"

  data_available_for_request:
    description: >
      Whether users may request access to this data.
    type: boolean

# Can be mapped to HL7 FHIR ResearchStudy.sponsor
# Required property for Gen3 Pidgin
  creator:
    description: >
      An organization that initiates the investigation and is legally responsible for the study.
    type: string

  collaborators:
    description: >
      Other organizations (if any) providing support. Support may include funding, design, implementation, data analysis or reporting. The responsible party is responsible for confirming all collaborators before listing them.
    type: string

# HL7 FHIR definition
  principle_investigator:
    description: >
      A researcher in a study who oversees multiple aspects of the study, such as concept development, protocol writing, protocol submission for IRB approval, participant recruitment, informed consent, data collection, analysis, interpretation and presentation.
    type: string

  prs_account:
    description: >
      The account in the Protocol Registration and Results System that was used to register the clinical studu and to submit results information for the registered study.
    type: string

  verification_date:
    description: >
      The date on which the responsible party last verified the clinical study information in the entire ClinicalTrials.gov record for the clinical study, even if no additional or updated information is being submitted.
    type: string

  clinical_trial_website:
    description: >
      Any originating or affiliated website for the respective clinical trial.
    type: string

#Props needed for Pidgin
  contributor:
    description: >
      An entity responsible for making contributions to the resource. Examples of a Contributor include a person, an organization, or a service. Typically, the name of a Contributor should be used to indicate the entity.
    type: string

  coverage:
    description: >
      The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant. Spatial topic and spatial applicability may be a named place or a location specified by its geographic coordinates. Temporal topic may be a named period, date, or date range. A jurisdiction may be a named administrative entity or a geographic place to which the resource applies. Recommended best practice is to use a controlled vocabulary such as the Thesaurus of Geographic Names [TGN] (http://www.getty.edu/research/tools/vocabulary/tgn/index.html). Where appropriate, named places or time periods can be used in preference to numeric identifiers such as sets of coordinates or date ranges.
    type: string

  language:
    description: >
      A language of the resource. Recommended best practice is to use a controlled vocabulary such as RFC 4646 (http://www.ietf.org/rfc/rfc4646.txt).
    type: string

  publisher:
    description: >
      An entity responsible for making the resource available. Examples of a Publisher include a person, an organization, or a service. Typically, the name of a Publisher should be used to indicate the entity.
    type: string

  rights:
    description: >
      Information about rights held in and over the resource. Typically, rights information includes a statement about various property rights associated with the resource, including intellectual property rights.
    type: string

  source:
    description: >
      A related resource from which the described resource is derived. The described resource may be derived from the related resource in whole or in part. Recommended best practice is to identify the related resource by means of a string conforming to a formal identification system.
    type: string

  subject:
    description: >
      The topic of the resource. Typically, the subject will be represented using keywords, key phrases, or classification codes. Recommended best practice is to use a controlled vocabulary.
    type: string

  study_registration:
    description: >
      A string which will identify the repository where data for the study is stored.
    type: string

  study_registration_id:
    description: >
      A string which will identify the unique ID for the study within the repository where data for the study is stored.
    type: string

  required_idp:
    description: >
      The identity provider for the data set. Only users who have logged in via this identity provider can request access to this data.
    type: string

  external_url:
    description: >
      The external database url for a study.
    type: string

  projects:
    $ref: "_definitions.yaml#/to_one_project"
